This inventor holds 3 USPTO granted patents. Top assignee: Northeastern University. Active years: 2016-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Revere, MA (US) (2016)
- Boston, MA (US) (2018 - 2020)
Company Filing History:
Years Active: 2016-2020
Title: Innovations of Nikolai M Zvonok
Introduction
Nikolai M Zvonok is a prominent inventor based in Boston, MA. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for N-acylethanolamine hydrolyzing acid amidase (NAAA). With a total of three patents to his name, Zvonok's work is paving the way for advancements in therapeutic applications.
Latest Patents
Zvonok's latest patents focus on N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their applications. One of his notable patents describes a compound represented as Formula I, which includes a tautomer, a stereoisomer, or a pharmaceutically acceptable salt thereof. These compounds serve as inhibitors of NAAA, which is crucial for treating conditions mediated by this enzyme. The technology encompasses compounds, compositions, and methods aimed at inhibiting NAAA and addressing related medical conditions.
Career Highlights
Zvonok is affiliated with Northeastern University, where he continues to engage in innovative research. His work has garnered attention for its potential impact on therapeutic strategies, particularly in pain management and other related health issues.
Collaborations
Zvonok collaborates with esteemed colleagues, including Alexandros Makriyannis and Michael Sotirios Malamas. Their combined expertise enhances the research efforts and contributes to the advancement of their shared goals in biochemistry.
Conclusion
Nikolai M Zvonok's contributions to the field of biochemistry through his innovative patents highlight his role as a key inventor. His work on NAAA inhibitors showcases the potential for new therapeutic approaches, making a significant impact in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
